By Conor Coyle
Date: Wednesday 20 Jul 2016
LONDON (ShareCast) - (ShareCast News) - Abbott Laboratories reported better-than-expected quarterly sales and profit as strong demand for its medical device business came good.
However, the healthcare company also posted earnings declining by 22% from the previous year amid higher expenses.
The company posted a profit of $615m, or 41 cents per share, down from $784mn, or 52 cents per share, a year earlier.
Abbott, which takes in two-thirds of its revenue from outside the United States, said emerging market sales increased 1.1% but would have risen 4.8% excluding the impact of its Venezuelan operations.
Economic turmoil in Venezuela led to an inflation rate of 141.5% and a hit to any business involved in the country.
The company's results, however, beat Wall Street estimates, largely helped by its booming medical device arm, where sales rose 6.4% to $1.37bn in the second quarter.
Abbott is currently in the process of taking over St. Jude Medical to the tune of $25bn, in the middle of a flurry of activity in the healthcare market.
For the second quarter, sales rose 1.4% in Abbott's nutrition segment, the company's largest. Recently launched infant and toddler GMO-free baby food and formula and strong performance in several countries in Latin America and Asia drove a 4.3% increase on an operational basis.
Overall, sales climbed 3.2% at the same time as operational revenue, which factors out currency changes, increased 6.4%.
Email this article to a friend
or share it with one of these popular networks:
Currency | US Dollars |
Share Price | $ 103.68 |
Change Today | $ 0.23 |
% Change | 0.22 % |
52 Week High | $120.96 |
52 Week Low | $90.19 |
Volume | 3,683,145 |
Shares Issued | 1,734.08m |
Market Cap | $179,789m |
RiskGrade | 113 |
Strong Buy | 8 |
Buy | 8 |
Neutral | 7 |
Sell | 0 |
Strong Sell | 0 |
Total | 23 |
Time | Volume / Share Price |
16:00 | 619,584 @ $103.68 |
15:59 | 100 @ $103.69 |
15:59 | 200 @ $103.69 |
15:59 | 200 @ $103.69 |
15:59 | 200 @ $103.69 |
You are here: research